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Introduction
Serial lactate measurements provide a valuable tool to
risk-stratify patients, determine the presence of ongoing
tissue hypoperfusion, and potentially evaluate efficacy of
therapeutic interventions. Prior studies have shown lactate
clearance to be a valuable predictor of patient outcomes,
however some have defined adequate change in lactate by
a decrease from baseline by 10% whereas others consid-
ered an absolute reduction to lactate < 4mmol/L. We
hypothesize that a serial absolute lactate < 4mmol/L after
initial resuscitation will be as effective a predictor of future
mortality as a change by 10%.
Objectives
To compare the diagnostic characteristics of an absolute
serial lactate < 4 mmol/L after resuscitation with the more
traditional definition (>10% decrease in serum lactate).
Methods
Single-center retrospective study of patients presenting to
an urban tertiary care Emergency Department (ED) with
lactate >4mmol/L and suspected infection. Continuous
data was analyzed using a one-way ANOVA, whereas cate-
gorical data was compared using Fisher’s exact test.
Patients were stratified by lactate clearance using the tradi-
tional definition (>10% decrease in serum lactate) as well
as a novel definition (second lactate < 4mmol/L) and
compared.
Results
Median initial lactate was 5.2mmol/L [IQR 4.4-6.8]. The
average decrease in serum lactate was 26.7% [2.3-44.4].
In-hospital mortality was 26.7%. 109/161 (67.7%) patients
had >10% decrease in serum lactate, whereas 76/161
(47.2%) cleared lactate to < 4mmol/L. The average amount
of crystalloid fluid resuscitation received was 2,970 ml, and
the average time between lactate values was 181 minutes.
Among patients who cleared lactate by at least 10%, mor-
tality was 21.1% while those who did not clear their lactate
by 10% had 38.5% mortality (p = 0.02). The negative pre-
dictive value for in-hospital mortality among those who
clear their lactate by 10% was 78.9% [95% CI 69.8-85.9],
sensitivity was 46.5% [95% CI: 31.5-62.2] and specificity
was 72.9% [95% CI: 63.8-80.5]. Among patients who
cleared their lactate to < 4mmol/L, mortality was 14.5%,
while those who did not clear their lactate to < 4mmol/L
had a mortality of 37.6% (p = 0.001). The negative predic-
tive value for in-hospital mortality among those who clear
lactate to < 4mmol/L was 85.5% [95% CI 75.2-92.2], sensi-
tivity was 74.4% [58.5-86.0] and specificity was 55.1%
[45.7-64.2].
Conclusions
A serial lactate < 4mmol/L as compared to >10% change
has improved negative predictive value for in-hospital
mortality and may provide more utility for risk stratifica-
tion, assessment of response to therapy, and potentially
clinical decision-making.
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Table 1. Baseline Characteristics
Lactate decrease <10%
n = 52 (32.3)
Lactate decrease > 10%
n = 109 (67.7)
Serial Lactate > 4mmol/
L n = 85 (52.8)
Serial Lactate <4mmol/
L n = 76 (47.2)
Overall
Age 67.2 + 18.4 69.3 +15.2 68.4+17.9 69.0+14.4 68.6
+16.3
Initial Lactate, mmol/L 5.25 [4.4-7.1] 5.2 [4.4-6.7] 6 [4.9-8.6] 4.7 [4.3-5.3] 5.2[4.4-
6.8]




168 +109.7 188+80.2 163+99.5 202+75.9 181
+90.9
Volume Crystalloid in 3
hours, ml








22 (42.3) 32 (29.4) 35 (41.2) 19 (25.0) 54 (33.5)
ICU LOS, days 2.1 [1.1-4.6] 2.2 [1.3-5.9] 2.7 [1.2-5.9] 1.9[1.1-5.4] 2.2[1.1-
5.7]
In-Hospital Mortality 20 (38.5) 23 (21.1) 32 (37.6) 11 (14.5) 43 (26.7)












N 52 109 - 85 76 -
Initial Lactate, mmol/L 6.1 5.9 0.43 6.8 4.9 <
0.0001
Volume Crystalloid in 3
hours, ml
2971.7 2969.4 0.99 2850.5 3080.6 0.39
Vasopressors within 3 hours 22 (42.3) 32 (29.4) 0.11 35 (41.2) 19 (25.0) 0.04
In-hospital Mortality 20 (38.5) 23 (21.1) 0.02 32 (37.7) 11 (14.5) 0.001
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